WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

Army Enterprise LLM Workspace, which is powered by Ask Sage IL5 Software-as-a-Service, is hosted within the Army’s cArmy Cloud and is controlled-unclassified-information accredited, ...

CHICAGO – April 29, 2025 – Parallel Works, provider of the ACTIVATE control plane for hybrid multi-cloud computing resources, today announced the launch of ACTIVATE High Security Platform, a hybrid, ...

Snowflake Inc. says it’s ready to begin its military service after achieving a key authorization that certifies its cloud data warehouse technologies are suitable for storing sensitive, but not clas ...

Snowflake announces it received Department of Defense IL5 Provisional Authorization on AWS GovCloud US-West. The authorization enables the company to offer solutions requiring the highest levels ...

"Achieving IL5 authorization is a critical milestone for Snowflake, and as a mission partner, will be instrumental in our ability to serve defense agencies with the robust and compliant solutions ...

Snowflake’s IL5 authorization comes on the heels of establishing Snowflake Public Sector, Inc., a subsidiary dedicated to serving customers in the Federal, State and local government, national ...

Hypori’s SaaS-based IL5 environment, available on the Amazon Web Service (AWS) GovCloud, empowers DOD mission owners to securely access DOD networks without ever transmitting, processing or ...

Eosinophilic otitis media (EOM) is a type 2-related otitis media. Scientists at the Hirosaki University Graduate School of Medicine have developed a new EOM animal model in guinea pigs by using the ...

However, Roep said that ILC2 cells have been shown to play “a very important role” in the gut microbiome, and he “would not be surprised if there are signals from the gut microbiome that can ...

They discovered that mice missing a type of immune cell called ILC2 couldn't produce enough glucagon—the hormone that raises blood sugar—and their glucose levels dropped too low.

Gschwend A, Helbling A, Feldmeyer L, et al. Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS). Allergo J Int 2023;32:104-111.